Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

481 ARTÍCULOS , VIENDO DEL 1 AL 15

Recruitment and Screening Methods in Alzheimer's Disease Research: The FIT-AD Trial

Greimel S, Wyman JF, Zhang L, Yu F.

J Gerontol A Biol Sci Med Sci. 2022 Mar 3;77(3):547-553. doi: 10.1093/gerona/glab092.

Presenilin 1 Gene Mutation (M139V) in a German Family with Early-Onset Alzheimer's Disease: A Case Report

Fuentes M, Schipke CG, Freiesleben SD, Klostermann A, Peters O.

Arch Clin Neuropsychol. 2022 Feb 23;37(2):521-530. doi: 10.1093/arclin/acab070.

Association of Performance on Dichotic Auditory Tests With Risk for Incident Dementia and Alzheimer Dementia

Mohammed A, Gibbons LE, Gates G, Anderson ML, McCurry SM, McCormick W, Bowen JD, Grabowski TJ, Crane PK, Larson EB.

JAMA Otolaryngol Head Neck Surg. 2022 Jan 1;148(1):20-27. doi: 10.1001/jamaoto.2021.2716.

Traumatic brain injuries among veterans and the risk of incident dementia: A systematic review & meta-analysis

Leung KK, Carr FM, Russell MJ, Bremault-Phillips S, Triscott JAC.

Age Ageing. 2022 Jan 6;51(1):afab194. doi: 10.1093/ageing/afab194.

Dual-Phase 18F-Florbetaben PET/CT: Unsuspected Thalamic Infarction Mimicking Alzheimer Disease

Rudolphi-Solero T, Triviño Ibáñez EM, Aroui T, Navidad RH, Gómez-Río M.

Clin Nucl Med. 2022 Apr 1;47(4):333-335. doi: 10.1097/RLU.0000000000003955.

Is Amyloid Burden Measured by 18F-Flutemetamol PET Associated with Progression in Clinical Alzheimer's Disease?

Müller EG, Edwin TH, Strand BH, Stokke C, Revheim ME, Knapskog AB.

J Alzheimers Dis. 2022;85(1):197-205. doi: 10.3233/JAD-215046.

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease

Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, Suhy J, Forrestal F, Tian Y, Umans K, Wang G, Singhal P, Budd Haeberlein S, Smirnakis K.

JAMA Neurol. 2022 Jan 1;79(1):13-21. doi: 10.1001/jamaneurol.2021.4161.

Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach

Tripathi P, Shukla P, Bieberich E.

Curr Pharm Des. 2022;28(2):116-132. doi: 10.2174/1381612827666211122153946.

Research Criteria for the Behavioral Variant of Alzheimer Disease: A Systematic Review and Meta-analysis

Ossenkoppele R, Singleton EH, Groot C, Dijkstra AA, Eikelboom WS, Seeley WW, Miller B, Laforce RJ, Scheltens P, Papma JM, Rabinovici GD, Pijnenburg YAL.

JAMA Neurol. 2022 Jan 1;79(1):48-60. doi: 10.1001/jamaneurol.2021.4417.

Statins and dementia: effect of statins beyond the treatment of dyslipidaemia

Uzokov J.

Eur J Prev Cardiol. 2022 May 5;29(5):802-803. doi: 10.1093/eurjpc/zwab226.

The Efficacy and Safety of Alzheimer's Disease Therapies: An Updated Umbrella Review

Fan F, Liu H, Shi X, Ai Y, Liu Q, Cheng Y.

J Alzheimers Dis. 2022;85(3):1195-1204. doi: 10.3233/JAD-215423.

Stem Cell-based Therapeutic and Diagnostic Approaches in Alzheimer's Disease

Abdi S, Javanmehr N, Ghasemi-Kasman M, Bali HY, Pirzadeh M.

Curr Neuropharmacol. 2022;20(6):1093-1115. doi: 10.2174/1570159X20666211231090659.

Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities

Ismail Z, Creese B, Aarsland D, Kales HC, Lyketsos CG, Sweet RA, Ballard C.

Nat Rev Neurol. 2022 Mar;18(3):131-144. doi: 10.1038/s41582-021-00597-3. Epub 2022 Jan 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias